Study Raises Concerns About Wi-Fi Device Radiation and Sleep Quality

Summary: A study suggests that exposure to radiofrequency electromagnetic fields from Wi-Fi-enabled devices, such as baby monitors, may contribute to sleep disturbances. Conducted in real-world conditions, the research found that participants exposed to the radiation experienced disrupted sleep patterns, with some showing increased brain activity during non-REM sleep and a heightened risk of clinical insomnia.…

Read More

Investigational AXS-12 Reduces Cataplexy in Narcolepsy Patients 

Summary: Axsome Therapeutics’ AXS-12 (reboxetine) achieved significant results in the ENCORE phase 3 trial for narcolepsy with cataplexy, reducing cataplexy attacks by 77% over six months and improving excessive daytime sleepiness, cognition, and overall narcolepsy symptoms. The trial demonstrated AXS-12’s long-term safety and efficacy, with minimal adverse effects. The company plans to file a New…

Read More